Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 4

Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety

Authors Andrea Rossi, Sonia Khirani, Mario Cazzola

Published Date July 2008 Volume 2008:3(4) Pages 521—529

DOI http://dx.doi.org/10.2147/COPD.S1353

Published 27 July 2008

Andrea Rossi1, Sonia Khirani1, Mario Cazzola2

1Unit of Respiratory Diseases, Hospital of Bergamo, Bergamo, Italy; 2Unit of Respiratory Diseases, Department of Internal Medicine, University of Rome ‘Tor Vergata’, Rome, Italy

Abstract: COPD is characterized by progressive airflow obstruction which does not fully reverse to inhaled or oral pharmacotherapy. The management of patients with COPD has taken a totally new direction over the past 20 years, thank to the use of novel therapies aimed to improve and modify the natural history of COPD. Long-acting bronchodilators, including long-acting β2-agonists (LABAs), were introduced several years ago in order to enhance improvements in lung function, health status related quality of life, and reduce the rate of exacerbations. These effects can be boosted by the combination of LABAs with long-acting anticholinergic, and/or with inhaled corticosteroids. Inhaled LABAs are commonly well tolerated although adverse effects such as tremor and palpitations are occasionally troublesome.

Keywords: LABA, COPD, efficacy, safety

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Polyacrylonitrile nanofibers coated with silver nanoparticles using a modified coaxial electrospinning process

Yu DG, Zhou J, Chatterton NP, Li Y, Huang J, Wang X

International Journal of Nanomedicine 2012, 7:5725-5732

Published Date: 12 November 2012

Intraocular pressure in Japanese diabetic patients

Matsuoka M, Ogata N, Matsuyama K, Yoshikawa T, Takahashi K

Clinical Ophthalmology 2012, 6:1005-1009

Published Date: 2 July 2012

Double-pass microkeratome technique for ultra-thin graft preparation in Descemet's stripping automated endothelial keratoplasty

Hsu M, Hereth WL, Moshirfar M

Clinical Ophthalmology 2012, 6:425-432

Published Date: 16 March 2012

Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure

Takami T, Yamano S, Okada S, Sakuma M, Morimoto T, Hashimoto H, Somekawa S, Saito Y

Vascular Health and Risk Management 2012, 8:169-176

Published Date: 14 March 2012

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A

Vascular Health and Risk Management 2011, 7:693-699

Published Date: 22 November 2011

Novel drug-eluting stents in the treatment of de novo coronary lesions

Davide Capodanno, Fabio Dipasqua, Corrado Tamburino

Vascular Health and Risk Management 2011, 7:103-118

Published Date: 25 February 2011

Update on rabies

Alan C Jackson

Research and Reports in Tropical Medicine 2011, 2:31-43

Published Date: 2 February 2011

Improving adherence with inhaler therapy in COPD

Suzanne C Lareau, Barbara P Yawn

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:401-406

Published Date: 24 November 2010

Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells

Masahiko Ayaki, Atsuo Iwasawa, Yoichi Inoue

Clinical Ophthalmology 2010, 4:1217-1222

Published Date: 15 October 2010

Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma

Dimitris Papaconstantinou, Ilias Georgalas, George Kalantzis, Efthimios Karmiris, et al.

Clinical Ophthalmology 2009, 3:251-257

Published Date: 13 March 2009